Avid Bioservices Inc

NASDAQ: CDMO    
Share price (5/17/24): $9.12    
Market cap (5/17/24): $579 million
7 Avid Bioservices Inc Expert Interviews, now on BamSEC.
 Powered by Tegus.

Indentures Filter

EX-4.1
from 8-K 77 pages Avid Bioservices, Inc., as Issuer and U.S. Bank Trust Company, National Association, as Trustee Indenture Dated as of March 12, 2024 7.00% Convertible Senior Notes Due 2029
12/34/56
EX-4.4
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.4
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.4
from S-3ASR 46 pages Form of Indenture Avid Bioservices, Inc. Issuer and as Trustee Indenture Dated as of , 20 Debt Securities I
12/34/56
EX-4.4
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 4 pages Avid Spv, LLC, as Issuer, Avid Bioservices, Inc., as Guarantor and U.S. Bank National Association as Trustee First Supplemental Indenture Dated as of April 30, 2021 to Indenture Dated as of March 12, 2021 1.250% Exchangeable Senior Notes Due 2026
12/34/56
EX-4.1
from 8-K 112 pages Avid Spv, LLC, as Issuer Avid Bioservices, Inc., as Guarantor and U.S. Bank National Association, as Trustee Indenture Dated as of March 12, 2021 1.250% Exchangeable Senior Notes Due 2026
12/34/56
EX-4.21
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 1 page Amendment to Rights Agreement
12/34/56
EX-4.3
from S-8 4 pages Notice of Grant of Restricted Stock Unit Award (Time-Vesting) Avid Bioservices, Inc. 2018 Omnibus Incentive Plan
12/34/56
EX-4.2
from S-8 5 pages Notice of Grant of [Incentive/Non-Qualified] Stock Option Award Avid Bioservices, Inc. 2018 Omnibus Incentive Plan
12/34/56
EX-4.4
from S-3 45 pages Avid Bioservices, Inc. Issuer and as Trustee Indenture Dated as of , 20 Debt Securities
12/34/56
EX-4.1
from 8-K 54 pages Amended and Restated Rights Agreement by and Between Peregrine Pharmaceuticals, Inc. and Broadridge Corporate Issuer Solutions, Inc. as Rights Agent Amended and Restated as of March 16, 2016
12/34/56
EX-4.27
from 10-K 2 pages Form of Amendment to Stock Option Award Agreement Under the Peregrine Pharmaceuticals, Inc. 2011 Stock Incentive Plan
12/34/56
EX-4.26
from 10-K 1 page Form of Amendment to Non-Qualified Stock Option Agreement Under the Peregrine Pharmaceuticals, Inc. 2009 Stock Incentive Plan
12/34/56
EX-4.25
from 10-K 1 page Form of Amendment to Non-Qualified Stock Option Agreement Under the Peregrine Pharmaceuticals, Inc. 2005 Stock Incentive Plan
12/34/56
EX-4.24
from 10-K 1 page Third Amendment to the Peregrine Pharmaceuticals, Inc. 2011 Stock Incentive Plan
12/34/56
EX-4.23
from 10-K 1 page First Amendment to the Peregrine Pharmaceuticals, Inc. 2009 Stock Incentive Plan
12/34/56
EX-4.22
from 10-K 1 page First Amendment to the Peregrine Pharmaceuticals, Inc. 2005 Stock Incentive Plan
12/34/56
EX-4.20
from S-8 3 pages Form of Stock Option Award Agreement Under the Peregrine Pharmaceuticals, Inc. 2011 Stock Incentive Plan
12/34/56